J&J/Centocor’s Remicade Gains Pediatric Crohn’s Disease Indication
This article was originally published in The Pink Sheet Daily
Executive Summary
Remicade is the first Crohn's disease therapy approved for pediatric patients following its May 19 supplemental BLA approval